Aoyagi, T., & Kuroda, I. (2022). Castration-Synchronized Upfront Docetaxel for metastatic Hormone Sensitive Prostate Cancer considering Epithelial to Mesenchymal Transition. Medical Research Archives, 10(10). doi:10.18103/mra.v10i10.3235